Cantitate/Preț
Produs
Total produse
Vezi coșul
Making Markets for Vaccines: Ideas to Action de Ruth Levine

Making Markets for Vaccines: Ideas to Action

Editat de Ruth Levine, Michael Kremer, Alice Albright
en Limba Engleză Paperback – 29 apr 2005
Making a commitment in advance to buy vaccines if and when they are developed would create incentives for industry to increase investment in research and development. New commercial investment would complement funding of research and development by public and charitable bodies, accelerating the development of vital new vaccines for the developing world. This report presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. By creating arrangements that devote the same scientific effort to diseases of the poor as we put into diseases of the rich, we can make a lasting contribution to the defeat of poverty.
Citește tot Restrânge

Preț: 7712 lei

Preț vechi: 14042 lei
-45% Nou

Puncte Express: 116
Preț estimativ în valută:
1476€ • 1552$ • 1233£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781933286020
ISBN-10: 1933286024
Pagini: 113
Dimensiuni: 178 x 241 x 8 mm
Greutate: 0.49 kg
Editura: Brookings Institution Press
Colecția Center for Global Development
Locul publicării:United Kingdom

Notă biografică

Ruth Levine, senior fellow and Director of Programs at the Center for Global Development, currently leads the Center's Global Health Policy Research Network. Michael Kremer is a professor in the Department of Economics at Harvard University and senior fellow at the Brookings Institution. Alice Albright is the Chief Executive Officer for the Global Partnership for Education.

Descriere

Making a commitment in advance to buy vaccines if and when they are developed would create incentives for industry to increase investment in research and development. New commercial investment would complement funding of research and development by public and charitable bodies, accelerating the development of vital new vaccines for the developing world. This report presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. By creating arrangements that devote the same scientific effort to diseases of the poor as we put into diseases of the rich, we can make a lasting contribution to the defeat of poverty.